Stephen K. Burley
Corporate Officer/Principal presso The Rockefeller University
Posizioni attive di Stephen K. Burley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | 01/06/1997 | - |
Storia della carriera di Stephen K. Burley
Precedenti posizioni note di Stephen K. Burley
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | 18/04/2011 |
| CASCADIAN THERAPEUTICS INC (USA) | Direttore/Membro del Consiglio | 09/06/2008 | 04/09/2008 |
Prospect Genomics, Inc.
 Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Fondatore | 21/12/2009 | - |
| Corporate Officer/Principal | - | 21/12/2009 |
Formazione di Stephen K. Burley
| Harvard University | Doctorate Degree |
| University of Oxford | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 2 |
| Canada | 2 |
Posizioni
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Prospect Genomics, Inc.
Prospect Genomics, Inc. Packaged SoftwareTechnology Services Prospect Genomics, Inc. developed computational technology solutions for the pharmaceutical field. The company was headquartered in San Diego, CA. | Technology Services |
- Borsa valori
- Insiders
- Stephen K. Burley
- Esperienza
